DERMAGRAFT (HUMAN FIBROBLAST-DERIVED DERMAL SUBSTITUTE)
FDA premarket approval P000036/S017 · decided 2013-05-23
Approval details
- PMA number
- P000036
- Supplement
- S017
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- DERMAGRAFT (HUMAN FIBROBLAST-DERIVED DERMAL SUBSTITUTE)
- Generic name
- Dressing, wound and burn, interactive
- Applicant
- Shire Regenerative Medicine
- Date received
- 2013-04-24
- Decision date
- 2013-05-23
- Days to decision
- 29 days
- Decision code
- OK30
- Product code
- MGR
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- San Diego, CA
- Statement
- QUALIFICATION OF ADDITIONAL SEEDING VESSELS, AND PROPOSED A CHANGE IN THE TYPE OF MATERIAL USED FOR THE TUBING AND MANIFOLD ASSEMBLY CONNECTOR FITTINGS.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.